17 August 2020: Clinical Research
Evaluation of Ovarian Tumors with Multidetector Computed Tomography and Tumor Markers: Differentiation of Stage I Serous Borderline Tumors and Stage I Serous Malignant Tumors Presenting as Solid-Cystic Mass
Xin-Ping Yu 1BCE , Ying Liu 2C , Jin-Wen Jiao 1D , Hong-Juan Yang 1B , Rui-Jing Wang 1D , Shuai Zhang 3ACF*DOI: 10.12659/MSM.924497
Med Sci Monit 2020; 26:e924497
Figure 4 Receiver operating characteristic curves for age, CA125, HE4, maximum thickness of wall, maximum thickness of septa, maximum diameter of solid component and combination of age, vascular abnormalities and maximum diameter of solid component in differentiating SBOTs and SMOTs. CA125 – cancer antigen 125; HE4 – human epididymis protein 4; SBOTs – serous borderline ovarian tumors; SMOTs – serous malignant ovarian tumors.